These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Implantation of an implantable cardioverter-defibrillator in a patient on chronic hemodialysis. Pürerfellner H; Nesser HJ; Aichinger J; Stummvoll K; Steinbach K Clin Nephrol; 1993 Feb; 39(2):112-3. PubMed ID: 8448914 [No Abstract] [Full Text] [Related]
4. Inappropriate detection and therapy from an implantable cardioverter defibrillator due to atrial undersensing. Paraskevaidis S; Polymeropoulos K; Vassilikos V; Louridas G Pacing Clin Electrophysiol; 2005 Sep; 28(9):1002-4. PubMed ID: 16176546 [TBL] [Abstract][Full Text] [Related]
5. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient. Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071 [TBL] [Abstract][Full Text] [Related]
6. [Coronary bypass surgery and cardioverter-defibrillator implanted in patients with malignant ventricular arrhythmia and ischemic cardiopathy]. Primo J; Geelen P; Lorga Filho A; Wellens F; Brugada P Rev Port Cardiol; 1998 Feb; 17(2):163-7. PubMed ID: 9587212 [No Abstract] [Full Text] [Related]
7. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Proclemer A; Ghidina M J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096 [No Abstract] [Full Text] [Related]
8. Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death. Lin G; Dispenzieri A; Brady PA Eur Heart J; 2010 Jun; 31(12):1538. PubMed ID: 20061577 [No Abstract] [Full Text] [Related]
9. Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis. Wright BL; Grace AA; Goodman HJ Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):110-4; quiz 115. PubMed ID: 16446780 [TBL] [Abstract][Full Text] [Related]
10. Phantom shock in a patient with an implantable cardioverter defibrillator: case report. Prudente LA Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172 [No Abstract] [Full Text] [Related]
11. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium. Sakai Y; Sato Y; Matsuo S; Imai S; Kunimasa T; Matsumoto N; Saito S Int J Cardiol; 2007 May; 117(3):e104-6. PubMed ID: 17350119 [TBL] [Abstract][Full Text] [Related]
12. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies. Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283 [TBL] [Abstract][Full Text] [Related]
13. A technique to overcome high defibrillation thresholds for an implantable cardioverter defibrillator. Boos CJ; Bentall AJ; Marshall HJ Cardiol Young; 2009 Jun; 19(3):291. PubMed ID: 19224670 [No Abstract] [Full Text] [Related]
14. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger? Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822 [No Abstract] [Full Text] [Related]
15. Implantable cardioverter-defibrillator discharges despite successful termination of ventricular tachycardia by antitachycardia pacing. Ho RT Pacing Clin Electrophysiol; 2009 Jun; 32(6):791-3. PubMed ID: 19545344 [No Abstract] [Full Text] [Related]
16. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials. Rahimtoola SH Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756 [No Abstract] [Full Text] [Related]
17. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [TBL] [Abstract][Full Text] [Related]
18. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
19. Safety of vagus nerve stimulation in a patient with bipolar disorder and an implanted cardioverter-defibrillator. Müller H; Demling JH; Schütz P; Weigel D; Kornhuber J; Sperling W Acta Neurol Scand; 2010 Apr; 121(4):285-6; author reply 287-8. PubMed ID: 20175760 [No Abstract] [Full Text] [Related]
20. Implantation of a biventricular implantable cardioverter defibrillator via the femoral vein. Jourdier L; Swinburn J; Roberts D; Clague J Pacing Clin Electrophysiol; 2007 Apr; 30(4):571-2. PubMed ID: 17437585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]